Express

Pfizer COVID-19 Vaccine First To Seek US Emergency Approval

Emily Mason

Summary: Pfizer Inc. filed with US regulators for an emergency use authorization for its COVID-19 vaccine, as reported by Bloomberg. The request is seeking approval for an emergency shot aiming to aid immunization efforts against the virus which has brought global shutdowns and economic turmoil. The vaccine has been developed in partnership with BioNTech SE and has become ...

Pfizer Inc. filed with US regulators for an emergency use authorization for its COVID-19 vaccine, as reported by Bloomberg.

The request is seeking approval for an emergency shot aiming to aid immunization efforts against the virus which has brought global shutdowns and economic turmoil. The vaccine has been developed in partnership with BioNTech SE and has become the first to apply for emergency approval. 

An emergency clearance would allow Americans to access the vaccine before it’s granted full approval. The vaccine would be administed according to priority with older populations and medical professionals recieving the shots first. 

News broke earlier this week that Pfizer's vaccine was 95% effective during trials protecting people of all ages and ethnicities from developing symptoms. There have been no significant safety problems in the trial that includes nearly 44,000 participants.

By Emily Mason

Last Update:

Tags: ,,
Link: Pfizer COVID-19 Vaccine First To Seek US Emergency Approval   [Copy]
  • From Data Rights to Digital Property: Whistleblower Brittany Kaiser on Blockchain, RWA,... 5 days ago
  • The Base Chain's Ascent: How Deep Coinbase Integration and JPMorgan's Pilot Are Reshapi... 11 days ago
  • Tether in Trouble? U.S. Senate Just Passed a Law That Could Dethrone the $155B Stableco... 14 days ago
  • Justin Sun's Nasdaq Gamble: How Six Years Forged Ties with the Trump Family 15 days ago
  • The Crypto IPO Wave: From Fringe to Front Page 18 days ago
  • You need to login to comment.